 |
Genzyme/Geltex Pharmaceuticals Joint Venture
Title: Genzyme/Geltex Pharmaceuticals Joint Venture
Category: Society & Culture / Education
Details: Words: 2343 | Pages: 10.0 (approximately 235 words/page)
Genzyme/Geltex Pharmaceuticals Joint Venture
Early in 1997, Genzyme Corporation began negotiations with Geltex Pharmaceuticals in an attempt to launch a joint venture to market Geltex's first product, RenaGel. Geltex was a young biotech research company with only two products in its pipeline, and they didn't have the resources necessary to launch RenaGel on their own. Genzyme, on the other hand, was a quickly growing company that experienced revenues of 8 million in 1996. They were attracted to the joint venture with Geltex …showed first 75 words of 2343 total…
You are viewing only a small portion of the paper.
Please login or register to access the full copy.
|
|
…showed last 75 words of 2343 total…summarize:
*<Tab/>What is the likely enterprise value of the joint venture?<Tab/>(,513,370)
*<Tab/>How much of the venture should Genzyme acquire?<Tab/>0%
*<Tab/>How much should Genzyme pay for its interest?<Tab/><Tab/>[#TEXT2#]
Calculations for these numbers can be found in Appendix C, Exhibits 1 & 2
Need a custom written paper?
|
|
 |
